BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Biliktu M, Senol SP, Temiz-Resitoglu M, Guden DS, Horat MF, Sahan-Firat S, Sevim S, Tunctan B. Pharmacological inhibition of soluble epoxide hydrolase attenuates chronic experimental autoimmune encephalomyelitis by modulating inflammatory and anti-inflammatory pathways in an inflammasome-dependent and -independent manner. Inflammopharmacology 2020;28:1509-24. [PMID: 32128702 DOI: 10.1007/s10787-020-00691-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 O'Brien CE, Santos PT, Kulikowicz E, Lee JK, Koehler RC, Martin LJ. Neurologic effects of short-term treatment with a soluble epoxide hydrolase inhibitor after cardiac arrest in pediatric swine. BMC Neurosci 2020;21:43. [PMID: 33129262 DOI: 10.1186/s12868-020-00596-y] [Reference Citation Analysis]
2 Yavarpour-Bali H, Ghasemi-Kasman M. The role of inflammasomes in multiple sclerosis. Mult Scler 2021;27:1323-31. [PMID: 32539629 DOI: 10.1177/1352458520932776] [Reference Citation Analysis]
3 Zhou JT, Ren KD, Hou J, Chen J, Yang G. α‑rhamnrtin‑3‑α‑rhamnoside exerts anti‑inflammatory effects on lipopolysaccharide‑stimulated RAW264.7 cells by abrogating NF‑κB and activating the Nrf2 signaling pathway. Mol Med Rep 2021;24:799. [PMID: 34523697 DOI: 10.3892/mmr.2021.12439] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Cagli A, Senol SP, Temiz-Resitoglu M, Guden DS, Sari AN, Sahan-Firat S, Tunctan B. Soluble epoxide hydrolase inhibitor trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl)urea prevents hyperalgesia through regulating NLRC4 inflammasome-related pro-inflammatory and anti-inflammatory signaling pathways in the lipopolysaccharide-induced pain mouse model. Drug Dev Res 2021;82:815-25. [PMID: 33559150 DOI: 10.1002/ddr.21786] [Reference Citation Analysis]
5 Jonnalagadda D, Wan D, Chun J, Hammock BD, Kihara Y. A Soluble Epoxide Hydrolase Inhibitor, 1-TrifluoromethoxyPhenyl-3-(1-Propionylpiperidin-4-yl) Urea, Ameliorates Experimental Autoimmune Encephalomyelitis. Int J Mol Sci 2021;22:4650. [PMID: 33925035 DOI: 10.3390/ijms22094650] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Wu J, Sun J, Meng X. Pyroptosis by caspase-11 inflammasome-Gasdermin D pathway in autoimmune diseases. Pharmacol Res 2021;165:105408. [PMID: 33412278 DOI: 10.1016/j.phrs.2020.105408] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Liang F, Qin W, Zeng Y, Wang D. Modulation of Autoimmune and Autoinflammatory Diseases by Gasdermins. Front Immunol 2022;13:841729. [PMID: 35720396 DOI: 10.3389/fimmu.2022.841729] [Reference Citation Analysis]
8 Yin J, Wan J, Zhu J, Zhou G, Pan Y, Zhou H. Global trends and prospects about inflammasomes in stroke: a bibliometric analysis. Chin Med 2021;16:53. [PMID: 34233704 DOI: 10.1186/s13020-021-00464-9] [Reference Citation Analysis]
9 Guan XX, Rao DN, Liu YZ, Zhou Y, Yang HH. Epoxyeicosatrienoic Acids and Fibrosis: Recent Insights for the Novel Therapeutic Strategies. Int J Mol Sci 2021;22:10714. [PMID: 34639055 DOI: 10.3390/ijms221910714] [Reference Citation Analysis]